Alfred E. Tiefenbacher (GmbH & Co KG)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Alfred E. Tiefenbacher (GmbH & Co KG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011865
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alfred E. Tiefenbacher (GmbH & Co KG) (AET) is a healthcare products provider that develops active pharmaceuticals ingredients. The company’s products comprise cytotoxic drugs, hormones, OTC drugs, controlled drugs, herbal drugs, high potent drugs, new combination products, inhaler technologies, new delivery systems, modified release injection products and biosimilars. It offers products in the forms of tablets, capsules, solutions, patches, semisolids, injectables, ophthalmics, oral dissolving films, inhaled therapies and biologics. The company operates in India, Cyprus, Malta, China, Brazil and the US. AET is headquartered in Hamburg, Germany.

Alfred E. Tiefenbacher (GmbH & Co KG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Alfred E. Tiefenbacher Receives Technology of Pramipexole from Hyundai Pharmaceutical 10
Alfred E. Tiefenbacher Forms Joint Venture with Combino Pharm 11
Licensing Agreements 12
Hyundai Pharm Enters Into Licensing Agreement With Alfred E. Tiefenbacher For Pramipexole SR 12
Alfred E. Tiefenbacher (GmbH & Co KG) – Key Competitors 13
Alfred E. Tiefenbacher (GmbH & Co KG) – Key Employees 14
Alfred E. Tiefenbacher (GmbH & Co KG) – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Key Facts 2
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alfred E. Tiefenbacher (GmbH & Co KG), Deals By Therapy Area, 2011 to YTD 2017 8
Alfred E. Tiefenbacher (GmbH & Co KG), Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alfred E. Tiefenbacher Receives Technology of Pramipexole from Hyundai Pharmaceutical 10
Alfred E. Tiefenbacher Forms Joint Venture with Combino Pharm 11
Hyundai Pharm Enters Into Licensing Agreement With Alfred E. Tiefenbacher For Pramipexole SR 12
Alfred E. Tiefenbacher (GmbH & Co KG), Key Competitors 13
Alfred E. Tiefenbacher (GmbH & Co KG), Key Employees 14
Alfred E. Tiefenbacher (GmbH & Co KG), Subsidiaries 15
Alfred E. Tiefenbacher (GmbH & Co KG), Joint Venture 15

★海外企業調査レポート[Alfred E. Tiefenbacher (GmbH & Co KG)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • British Columbia Cancer Agency-医療機器分野:企業M&A・提携分析
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy …
  • Lincoln National Corporation:企業の戦略・SWOT・財務分析
    Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report Summary Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Arthur J. Gallagher & Co:企業のM&A・事業提携・投資動向
    Arthur J. Gallagher & Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arthur J. Gallagher & Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Circle Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Circle Pharma Inc (Circle Pharma) is a developer of cell permeable macrocyclic peptide therapies by combining structure-based computational design and synthetic chemistry. The company’s automated chemistry synthesis enable to assess, in parallel, multiple design hypotheses for given target, …
  • Alafair Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Alafair Biosciences Inc (Alafair Biosciences) is a medical device company that develops and commercialize surgical products for soft tissue repair and protection applications. The company develops products based on a non-cell adhesive hydrogel technology to protect and manage advanced wound …
  • Epiroc AB (EPI A):企業の財務・戦略的SWOT分析
    Epiroc AB (EPI A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Alvogen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Alvogen Inc (Alvogen) is a pharmaceutical company that develops, manufactures and markets generic pharmaceuticals, brand and over the counter (OTC) products. The company offers generic medications in the therapeutic areas of oncology, cardiology, respiratory, neurology and gastroenterology. …
  • KIYATEC Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary KIYATEC Inc (KIYATEC) is a biotechnology company that commercializes 3D cell culture technology. The company concentrates on data correlation to human clinical outcomes. It provides drug response profiling services for developing small molecule compounds and biologic drugs. KIYATEC offers cu …
  • QuadraMed Corp:企業の戦略的SWOT分析
    QuadraMed Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Larsen & Toubro Ltd (LT):企業の財務・戦略的SWOT分析
    Larsen & Toubro Ltd (LT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dialog Group Berhad (DIALOG)-石油・ガス分野:企業M&A・提携分析
    Summary Dialog Group Berhad (Dialog) is an oil and gas services company. It provides integrated technical services. The company provides technical services for logistics and upstream assets; engineering, procurement, construction, and commissioning; plant maintenance and catalyst handling; fabricati …
  • Korea Electric Power Corporation:発電所・企業SWOT分析
    Korea Electric Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • YTL Power International Bhd (YTLPOWR):企業の財務・戦略的SWOT分析
    YTL Power International Bhd (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • BPH Energy Ltd (BPH):企業の財務・戦略的SWOT分析
    BPH Energy Ltd (BPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • OncBioMune Pharmaceuticals Inc (OBMP):企業の財務・戦略的SWOT分析
    Summary OncBioMune Pharmaceuticals Inc (OncBioMune), formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for cancer types such as renal, breast, prostrate, and ovarian cancer. It …
  • Prinzhorn Holding GmbH:企業の戦略・SWOT・財務情報
    Prinzhorn Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Prinzhorn Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mayo Clinic-医療機器分野:企業M&A・提携分析
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • Opthea Ltd (OPT):企業の財務・戦略的SWOT分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vasc …
  • The Federal Bank Limited:企業の戦略・SWOT・財務分析
    The Federal Bank Limited - Strategy, SWOT and Corporate Finance Report Summary The Federal Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Harman International Industries Inc:企業の戦略的SWOT分析
    Harman International Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆